Apoptosis and cancer chemotherapy
1CRC Molecular and Cellular Pharmacology Group, School of Biological Sciences, G38 Stopford Building, Oxford Road, Manchester, UK M13 9PT. guy.makin@man.ac.uk
Abstract:
The explosion of interest in apoptosis amongst cancer biologists has been underpinned by the hope that a mechanistic understanding of cell death will inform our understanding of tumour drug resistance. A framework for drug-induced apoptosis can now be described in which a balance exists between intrinsic and extrinsic survival signals and drug-induced death signals. Pro- and anti-apoptotic signals impact upon pro-apoptotic members of the Bcl-2 family of proteins, which ultimately control the cellular fate. This framework suggests multiple points at which therapeutic interventions could be made to overcome drug resistance and, in addition, generates novel molecular targets for the induction of apoptosis in cancer cells.
Insights
Understanding drug-induced apoptosis is key to overcoming cancer drug resistance. A new framework highlights how balancing survival and death signals, particularly involving Bcl-2 family proteins, offers therapeutic targets for cancer treatment.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cell Death Mechanisms
Background:
- Growing interest in apoptosis (programmed cell death) among cancer biologists.
- Hope that understanding cell death mechanisms will elucidate tumor drug resistance.
- Need for a framework to understand drug-induced apoptosis in cancer.
Purpose of the Study:
- To describe a framework for drug-induced apoptosis in cancer.
- To identify how intrinsic and extrinsic survival signals interact with drug-induced death signals.
- To explore therapeutic intervention points for overcoming drug resistance.
Main Methods:
- Analysis of the balance between pro- and anti-apoptotic signals.
- Investigation of the role of Bcl-2 family proteins in controlling cellular fate.
- Framework development based on mechanistic understanding of apoptosis.
Main Results:
- A framework for drug-induced apoptosis has been described.
- Pro- and anti-apoptotic signals converge on Bcl-2 family proteins.
- This balance dictates the ultimate cellular fate.
Conclusions:
- The described framework identifies multiple points for therapeutic intervention against drug resistance.
- Novel molecular targets for inducing apoptosis in cancer cells have been generated.
- Mechanistic insights into apoptosis can inform cancer drug resistance strategies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against specific...


